1-Hydrazinophthalazine (Apresoline in the) reatment of Hypertension: A Two Year Study | Zendy

Joseph H. Hafkenschiel | Zendy; M. Lindauer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

1-Hydrazinophthalazine (Apresoline in the) reatment of Hypertension: A Two Year Study

Author(s) -

Joseph H. Hafkenschiel,

M. Lindauer

Publication year - 1953

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.7.1.52

Subject(s) - medicine , blood pressure , life expectancy , cardiology , surgery , population , environmental health

Patients with severe essential hypertension have been carefully studied periodically in an attempt to group them as to probable life expectancy. Forty such patients have been observed while on oral 1-hydrazinophthalazine and a low salt diet. Nineteen of the 33 patients in the groups having a relatively good prognosis for survival had some decrease in diastolic pressure. Only one of seven patients in Smithwick group IV had a satisfactory reduction in blood pressure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research